Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epidermal cell thymocyte-activating factor.

D N Sauder1

  • 1Department of Medicine, McMaster University Health Science Centre, Hamilton, Ontario, Canada.

Advances in Dermatology
|January 1, 1986
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microarray analysis of UVB-regulated genes in keratinocytes: downregulation of angiogenesis inhibitor thrombospondin-1.

Journal of dermatological science·2004
Same author

Imiquimod: modes of action.

The British journal of dermatology·2003
Same author

Modulation of the contact hypersensitivity response by AE-941 (Neovastat), a novel antiangiogenic agent.

Journal of cutaneous medicine and surgery·2003
Same author

Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts.

The Journal of investigative dermatology·2001
Same author

Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis.

Acta dermato-venereologica·2001
Same author

Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies.

Journal of leukocyte biology·2001
Same journal

Uncommon benign infantile vascular tumors.

Advances in dermatology·2009
Same journal

Advances in hair diseases.

Advances in dermatology·2009
Same journal

Cutaneous mosaicism: a molecular and clinical review.

Advances in dermatology·2009
Same journal

Current concepts: dermatopathology of pigmentary alteration disorders in the Hispanic population.

Advances in dermatology·2009
Same journal

Recent advances in acne vulgaris research: insights and clinical implications.

Advances in dermatology·2009
Same journal

Update on the natural history and systemic treatment of psoriasis.

Advances in dermatology·2009
See all related articles

The study explores the multifaceted biological effects of Endothelial-derived thymocyte activating factor (ETAF). ETAF influences immune cell proliferation, fever response, and inflammation, potentially acting as a single cytokine or a group of related cytokines.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Endothelial-derived thymocyte activating factor (ETAF) exhibits diverse biological activities.
  • The precise mechanism, whether via a single cytokine or multiple related ones, remains under investigation.

Purpose of the Study:

  • To elucidate the range of biological effects mediated by ETAF.
  • To understand the potential signaling pathways and cytokine interactions involved in ETAF's actions.

Main Methods:

  • The abstract does not specify methods.
  • Literature review and analysis of existing data on ETAF's functions.

Main Results:

  • ETAF enhances thymocyte proliferation, hypothalamic fever response, leukocyte chemotaxis, and hepatic acute-phase protein synthesis.

Related Experiment Videos

  • It also induces muscle proteolysis, augments IL-2 production, and stimulates fibroblast and keratinocyte growth.

    • Conclusions:

    • ETAF possesses multiple divergent biologic effects, impacting both local and systemic immune responses.
    • Its actions may be mediated by a single cytokine or a family of related cytokines, similar to IL-1 or interferons.
    • ETAF likely plays a significant role in inflammatory and immunologic events.